摘要
目的 :评价微导管在支气管动脉灌注栓塞治疗中晚期肺癌及大咯血的临床应用价值 .方法 :用微导管超选择性支气管动脉灌注栓塞治疗中晚期肺癌 5 2例及肺大咯血 2 0例 .结果 :全部病例超选择性插管成功 ,成功率 10 0 % ,治疗后肺癌组完全缓解 (CR) 8例 ;部份缓解 (PR) 32例 ;稳定 (S) 12例 ;进展 (P)0例 ;术后 1,2 ,3a生存率分别为 10 0 % ,75 % ,4 0 % .咯血组BAE术后即期止血 16例 ,显效 4例 ,无效 0例 ,总有效率 10 0 % ;全部病例均未出现并发症 .结论 :在支气管动脉栓塞术中应用微导管安全 。
Objective: To evaluate the value of microcatheter superselective bronchial artery enbolization (SBAE) treating advanced bronchogenic carcinoma and massive hemoptysis. Methods: 52 patients with advanced bronchogenic carcinoma and 20 patients with massive hemoptysis were performed by SBAE respectively. Results: The catheterization was successful in all procedures (100%). The total effective rate of treating bronchogenic carcinoma was 100%. The survival rate at 1,2,3 years was 100%, 90%, 40% respectively. Immediate and complete control of hemoptysis was achieved in 15 patients. Marked reduced bleeding was seen in 5 patients. No serious complication occurred in all patients. Conclusion: Microcatheter for superselective bronchial artery embolization is an effective and safe procedure for treating advanced bronchial carcinoma and controlling massive hemoplysis and complications can be avoided.
出处
《昆明医学院学报》
2004年第1期70-73,共4页
Journal of Kunming Medical College
关键词
微导管
支气管动脉栓塞术
临床应用
肺癌
大咯血
Microcatheter
Bronchial artery
Embolization
Bronchial carcinoma
Hemoptysis
Therapy